Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 50009665
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086387(5-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-1H-[...)
Affinity DataIC50: 35nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086377(4-Benzyl-1-[2-(1H-imidazol-2-ylsulfanyl)-ethyl]-pi...)
Affinity DataIC50: 70nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50078480(4-[4-(4-Benzyl-piperidin-1-yl)-but-1-ynyl]-phenol ...)
Affinity DataIC50: 100nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086383(4-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-phen...)
Affinity DataIC50: 100nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086368(4-Benzyl-1-[2-(2H-[1,2,4]triazol-3-ylsulfanyl)-eth...)
Affinity DataIC50: 130nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086375(4-Benzyl-1-[2-(5-methyl-2H-[1,2,4]triazol-3-ylsulf...)
Affinity DataIC50: 150nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086386(5-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-[1,3...)
Affinity DataIC50: 210nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086378(2-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-3H-i...)
Affinity DataIC50: 240nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086376(2-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-1H-b...)
Affinity DataIC50: 380nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086372(5-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-[1,...)
Affinity DataIC50: 560nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086388(4-Benzyl-1-[3-(1H-imidazol-2-ylsulfanyl)-propyl]-p...)
Affinity DataIC50: 610nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086385(4-Benzyl-1-[3-(2H-[1,2,4]triazol-3-ylsulfanyl)-pro...)
Affinity DataIC50: 630nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086384(5-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50: 630nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086371(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-5-n...)
Affinity DataIC50: 910nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086382(4-Benzyl-1-(2-phenylsulfanyl-ethyl)-piperidine | C...)
Affinity DataIC50: 930nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086381(4-Benzyl-1-[3-(5-methyl-2H-[1,2,4]triazol-3-ylsulf...)
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086374(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086380(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-3H-...)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086370(4-Benzyl-1-(3-phenylsulfanyl-propyl)-piperidine | ...)
Affinity DataIC50: 4.30E+3nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086373(4-Benzyl-1-[2-(5-methyl-[1,3,4]thiadiazol-2-ylsulf...)
Affinity DataIC50: 4.80E+3nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086369(4-Benzyl-1-[3-(5-methyl-[1,3,4]thiadiazol-2-ylsulf...)
Affinity DataIC50: 6.40E+3nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086379(2-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-5-ni...)
Affinity DataIC50: 7.40E+3nMAssay Description:Antagonistic activity against NR1A/2B receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086383(4-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-phen...)
Affinity DataIC50: 3.50E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086374(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50: 5.10E+4nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086385(4-Benzyl-1-[3-(2H-[1,2,4]triazol-3-ylsulfanyl)-pro...)
Affinity DataIC50: 5.10E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086371(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-5-n...)
Affinity DataIC50: 6.10E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086374(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50: 6.40E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086372(5-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-[1,...)
Affinity DataIC50: 7.30E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086376(2-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-1H-b...)
Affinity DataIC50: 7.50E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086384(5-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50: 7.70E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086388(4-Benzyl-1-[3-(1H-imidazol-2-ylsulfanyl)-propyl]-p...)
Affinity DataIC50: 7.70E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086370(4-Benzyl-1-(3-phenylsulfanyl-propyl)-piperidine | ...)
Affinity DataIC50: 8.50E+4nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086373(4-Benzyl-1-[2-(5-methyl-[1,3,4]thiadiazol-2-ylsulf...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086387(5-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-1H-[...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086383(4-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-phen...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086388(4-Benzyl-1-[3-(1H-imidazol-2-ylsulfanyl)-propyl]-p...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086386(5-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-[1,3...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086369(4-Benzyl-1-[3-(5-methyl-[1,3,4]thiadiazol-2-ylsulf...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086377(4-Benzyl-1-[2-(1H-imidazol-2-ylsulfanyl)-ethyl]-pi...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086387(5-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-1H-[...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50078480(4-[4-(4-Benzyl-piperidin-1-yl)-but-1-ynyl]-phenol ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086384(5-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-1H-...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086368(4-Benzyl-1-[2-(2H-[1,2,4]triazol-3-ylsulfanyl)-eth...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086375(4-Benzyl-1-[2-(5-methyl-2H-[1,2,4]triazol-3-ylsulf...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086382(4-Benzyl-1-(2-phenylsulfanyl-ethyl)-piperidine | C...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086381(4-Benzyl-1-[3-(5-methyl-2H-[1,2,4]triazol-3-ylsulf...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086371(2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-5-n...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2C(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086381(4-Benzyl-1-[3-(5-methyl-2H-[1,2,4]triazol-3-ylsulf...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2C receptor in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086379(2-[2-(4-Benzyl-piperidin-1-yl)-ethylsulfanyl]-5-ni...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlutamate receptor ionotropic, NMDA 2A(Human)
Parke-Davis Pharmaceutical Research

Curated by ChEMBL
LigandPNGBDBM50086373(4-Benzyl-1-[2-(5-methyl-[1,3,4]thiadiazol-2-ylsulf...)
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonistic activity against NR1A/2A receptors in frog oocytesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: